Glycocalyx degradation causes increased endothelial permeability, increased pro-inflammatory cell migration, and the disruption of mechanotransduction and eNOS activity [30], resulting in the development of endogenous NO deficiency, which aggravates the development of endothelial dysfunction. The gene discussed is NOS3; the disease is endothelial dysfunction.